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Abstract
Objectives Critical limb ischemia (CLI) is a clinical diagnosis, confirmed by objective tests, usually ankle-brachial
index (ABI), toe pressure (TP) and TcPO2. Furthermore, the anatomical lesions in patients affected by CLI were
visualized by ultrasound, angiography, CTA, or MRA. Indocyanine green fluorescence imaging (ICG-FI) is a
diagnostic modality for assessing foot perfusion. We aimed to study the usefulness of ICG-FI in the quality control of
revascularization.
Materials and methods One hundred and four CLI limbs in 101 patients were studied with ICG-FI using SPY Elite
before and after open or endovascular revascularization. ABI and TP were also measured. After ICG-FI, assessment
of circulation was done using time–intensity curve derived from the two regions of interest the one being in the
plantar side of the foot and the other in the dorsal side of the foot. Three parameters were derived from the curves:
maximum intensity (the absolute value of the maximum intensity); intensity rate (the value from the time–intensity
curve describing the increase in maximum intensity/s) and SPY10 (the intensity achieved during the first 10 s after
the foot starts to gain intensity).
Results Sixty-two limbs presented category 3 of Rutherford classification, 12 limbs category 4, and 30 limbs
category 5. Ninety-five technically successful procedures were achieved, 63 (66.3%) endovascular and 32 (33.7%)
surgical revascularizations. In 9 (9.5%) patients, an in-line flow from the aorta to the foot was not achieved due to a
failure to recanalize the occlusion (n = 7) or due to distal embolization (n = 2). ABI was not reliable in 58 patients
(57.4%) mostly due to pseudohypertension and TPs in 49 (48.5%) patients mostly due to previous minor amputations.
ICG-FI was successful in all patients. The mean intensity values before and after the procedure in patients who
underwent successful revascularization were 81 ± 47 units and 120 ± 5 units of intensity (p\ .001) and intensity
rates 4.2 ± 4 and 8.0 ± 6.2 units/s (p = .001), respectively. In the PTA patients in whom the revascularization was
unsuccessful, no changes were seen in the hemodynamic parameters. In 6 (8.8%) patients who underwent technically
successful revascularization, the SPY values were worse after the revascularization than at the baseline.
Conclusions ICG-FI with SPY Elite provides reliable information on the increase in perfusion after revasculariza-
tion, in addition to implicating possible failure if there is no improvement in the ICG-FI variables. Unlike ABI and
TP, it can be performed in all patients. It gives valuable information to complement traditional assessment methods.
Introduction
Critical limb ischemia (CLI) is a significantly morbid dis-
ease that increases the risk of amputation and mortality.
The prevalence of CLI is increasing as the population ages
and the incidence of diabetes grows. Revascularization is
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recommended to obtain wound healing and limb salvage
[1].
CLI is a clinical diagnosis, but it should be supported by
objective tests. Multiple methods are utilized to determine
foot perfusion and the extent of arterial lesions, including
the ankle-brachial index (ABI), toe pressure (TP) and
TcPO2, as well as Doppler measurement, duplex ultra-
sound scanning, and other more invasive procedures such
as a CT scan and angiography [1]. Furthermore, the
assessment of the increase in the perfusion after revascu-
larization is important. After bypass surgery, this is usually
evident and a ‘‘red hot foot’’ tells about a successful pro-
cedure. However, after endovascular revascularization the
situation is often not so evident. After technically suc-
cessful PTA, the clinical picture of the wound and foot may
be unchanged and toe pressures may not show huge
increase or in some cases they are impossible to measure
[2].
Fluorescent angiography using indocyanine green (ICG)
has been demonstrated in reconstructive surgery to identify
territories of adequate and inadequate perfusion [3, 4] in
order to decrease complications and increase the early
detection of ischemic tissues on the flaps [5]. Near-infrared
fluorescence imaging is a noninvasive and non-ionizing
diagnostic modality for assessing the perfusion of tissues.
Although some publications exist on the use of fluores-
cence imaging in the assessment of ischemic feet, the
technique is uncommon in vascular surgery. Few studies
are available on patients with peripheral arterial disease
[6–9]. Terasaki et al. [6] introduced the use of two
parameters, PDE10 and T1/2 derived from the time–in-
tensity curve, to be used in the assessment of foot perfu-
sion. PDE10 is the intensity of the fluorescence 10 s from
the origin of the curve, and T1/s is the time in seconds that
is needed to achieve half of the maximum intensity.
In the current study, we utilized the fluorescence
imaging technique in the assessment of foot perfusion
before and after revascularization in patients with CLI. The
aim was to study the usefulness of ICG imaging in the
immediate quality control of revascularization and the
sensitivity of the technique to distinguish early failures in
the revascularization. Furthermore, we analyzed the dif-
ferences in the increase in the perfusion between surgical
bypass and endovascular revascularization.
Materials and methods
Altogether 750 infrainguinal endovascular procedures and
200 surgical bypasses due to CLI are performed in our
institution annually. During September 2015 and March
2016, 101 patients and 104 limbs treated with infrainguinal
endovascular or surgical revascularization due to CLI were
studied with an indocyanine green fluorescence imaging
using SPY device (SP 3055 Novadaq) before and after
revascularization (Fig. 1). The system is equipped with an
806 nm light-emitting diode (LED) as an excitation light
source and a charge-coupled device (CCD) camera covered
with a lens that filters out light with a wavelength of
830 nm.
Data on the patients’ risk factors and the status of the
ischemic foot as well as the details of the endovascular or
surgical revascularization were collected prospectively.
One-third (29%, n = 30/104) of the patients had previous
revascularization in history (31% of the surgical and 28%
of the endovascular patients). Data on atherosclerotic
lesions in lower-limb arteries were collected from either
magnetic resonance angiography or digital subtraction
angiography.
Assessment of the hemodynamic changes achieved
with revascularization
ABI and TP were measured in all patients preoperatively
and after revascularization. It was not possible to measure
ABI mostly due to the uncompressible arteries at the ankle
level both before and after the revascularization in 58
patients (57.4%) and toe pressures mostly due to previous
minor amputations in 49 (48.5%) patients. ICG-FI was
successful in all patients, and it was performed before and
after revascularization.
Fig. 1 Setup for the ICG-FI. In a darken room, a SPY camera is
positioned above the foot of the patient and ICG-FI is recorded
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The measurements were taken in a room with no day-
light and a temperature of 20–25 C. After a 15-min rest,
the patients lay in the supine position. The ICG-FI camera
was positioned 20 ± 3 cm above the plantar region of the
foot. ICG (0.1 mg/kg) was injected intravenously to the
brachial vein, and a 4-min continuous recording was
immediately initiated. Twenty minutes after the first
recording was finished, the examination was repeated on
the dorsum of the foot. The 20-min break between the two
examinations was held in order to let the ICG from the first
study to disappear from the body before the new
examination.
The SPY Elite device provided a time–intensity curve of
the selected region of interest (ROI) showing the fluores-
cence intensity plotted against time in seconds [10]
(Fig. 2). Three parameters were derived from the time–
intensity curve: (1) maximum intensity, which is the
absolute value of the maximum intensity in the time–in-
tensity curve; (2) intensity rate, which is the value from the
time–intensity curve describing the increase in maximum
intensity per seconds; and (3) Spy10, which is the intensity
achieved during the first 10 s after the foot starts to gain
intensity. Two ROIs were used in all cases—the first in the
dorsum of the foot and the second in the plantar region.
The mean value of these two measurements was used for
the analysis. The variables extracted from the time–inten-
sity curve of the ICG-FI were compared with ABI and TP.
During the ICG-FI recording, an automatic baseline setting
allowing adjustment for possible confounding factors, such
as possible daylight or residual ICG in the second mea-
surement, was used.
The study was approved by the Ethics Committee of our
institution. Informed consent was not asked as the ICG-FI
is in routine use for patients with CLI in our department.
Statistical analysis
SPSS 22.0 was used in statistical analysis. The continuous
variables are expressed as mean ± SD and range.
Dichotomous variables are expressed as percentages.
Comparison of the continuous variables before and after
revascularization was made using repeated samples t test.
The results were analyzed separately for the endovascular
procedures (PTA group) and surgical revascularization
(bypass group).
Results
The mean age of the patients was 76.2 (±11.2) years, and
53.8% have diabetes. The basic demographics of the study
patients and anatomical details of the revascularizations are
presented in Table 1. Sixty-two limbs presented category 3
of Rutherford classification [11], 12 limbs category 4, and
Fig. 2 ICG-FI image and time–intensity curve drawn of the region of interest before (above) and after (below) the revascularization showing
intensity (ingress) and intensity (ingress) rate values (time–intensity curve, SPY-image, regions we measured)
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30 limbs category 5. Of the 104 procedures, 10 (9.6%)
were performed to SFA, 31 (29.8%) to popliteal artery, and
63 (60.6%) to crural arteries. In 9 (9.5%) legs, an open line
from the aorta to the foot was not achieved due to a failure
to recanalize the occlusion (n = 7) or due to distal
embolization (n = 2). These 9 procedures were analyzed
separately. There were no immediate technical failures of
bypass surgery. Of the 95 technically successful proce-
dures, 63 (66.3%) were endovascular and 32 (33.7%) sur-
gical revascularizations.
The mean ABI increased from the baseline 0.41 (±0.14,
range 0.17–1.04) to a 0.85 (±0.2, range 0.22–1.38)
(p\ .001) after the revascularization, and toe pressures
increased from 29 (±12, range 12–125) to 49 (±20, range
15–103) (p = .07).
ICG injections were well tolerated by all patients, with
no adverse events related to this procedure. The mean
intensity values before and after the procedure in patients
who underwent successful revascularization were 81 ± 47
units (range 15–242) and 120 ± 5 units (range 27–245);
mean intensity rate values were 4.2 ± 4.9 (range
0.1–25.1) units/s before the revascularization and
8.0 ± 6.2 (range 0.2–31.3) units/s after the revasculariza-
tion (p = .001). SPY10 intensity was 26 ± 26 units (range
1–139) and 59 ± 42 units (range 2–203) (p\ .001).
In the 9 patients in whom the endovascular revascular-
ization was unsuccessful, no changes were seen in the
hemodynamic parameters. The changes in hemodynamic
parameters after failed and successful endovascular pro-
cedures and surgical repair are presented in Table 2.
In 6 (6.3%) patients, who underwent technically suc-
cessful revascularization, the SPY values were worse after
the revascularization than at the baseline. Three of them
underwent a distal puncture of the crural vessel and the
stenosis was recanalized from a retrograde direction
(Fig. 3). Later, duplex ultrasound showed thrombosis of
the artery distal to the puncture, explaining the SPY results.
In 3 (3.2%) bypass patients, the SPY variables were worse
after the revascularization than at the baseline. In two of
them, the bypass was occluded, and one had a significant
inflammation of the foot when the preoperative SPY was
performed, causing a falsely good time–intensity curve.
Discussion
Revascularization in patients affected by CLI improves leg
salvage and survival. However, most of the patients need
continuous surveillance of the revascularization and the
foot to achieve wound healing and to prevent amputation.
Furthermore, it is important to ensure the result of the
revascularization by measuring the arterial perfusion
before and after the revascularization. The conventional
methods for assessing the perfusion of the foot in patients
with critical limb ischemia are the ankle-brachial index
(ABI) and toe pressure [1]. The use of these methods with
TcPO2 can be helpful to make a quantitative analysis of
foot perfusion. Although these methods are validated by
TASCII [1], their use is, to a degree, limited, and they
cannot always be applied [12, 13].
An ICG-FI is a noninvasive modality for assessing the
perfusion of the tissues. It is easy to use and safe [14, 15].
Several studies have demonstrated the benefits of fluores-
cence imaging in medical applications such as retinal
angiography, liver clearance testing, and cardiac output
monitoring, but also in neurosurgery as well as cardiac,
Table 1 Basic demography of the patients and anatomical details of the revascularization
Bypass PTA Total
Number of patients/limbs 33/33 68/71 101/104
Age (years ± SD) 74 ± 11 76 ± 11 76 ± 11.2
Gender n (%) 12 F (36.4) 40 F (58.8) 52 F (51.5)
21 M (63.6) 28 M (41.2) 49 M (48.5)
Diabetes n (%) 18 (54.5) 36 (50.7) 56 (55.4)
Hypertension n (%) 30 (90.9) 57 (80.3) 90 (89.1)
Cardiac risk factors n (%) 10 (30.3) 22 (31.0) 32 (31.7)
Dyslipidemia n (%) 31 (93.9) 56 (78.9) 90 (89.1)
Stroke n (%) 6 (18.2) 10 (14.1) 16 (15.8)
Active smoking n (%) 7 (21.2) 13 (18.3) 20 (19.2)
Previous smoking n (%) 13 (39.4) 13 (18.3) 26 (25.0)
SFA revasc. n (%) 0 (0) 10 (14.7) 10 (9.6)
Popliteal artery revasc. n (%) 16 (48.5) 15 (22.1) 31 (29.8)
Crural revasc. n (%) 17 (51.5) 46 (67.6) 63 (60.6)
SFA superficial femoral artery, F female, M male
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reconstructive, and general surgery [16]. However, only
few studies exist on the ICG in vascular surgery [6–8, 17],
and even less is known about the use of SPY in patients
with critical limb ischemia. In the current study, we eval-
uated the use of ICG-FI in the assessment of an ischemic
foot as well as in the quality control of revascularization in
109 patients. We demonstrated that SPY is useful, espe-
cially when studying the change in circulation after
revascularization. Furthermore, it has some advantages
over the conventional methods and provides more reliable
quantitative information on the perfusion of the foot.
The concept of ICG-FI is relatively old but has not been
utilized in vascular surgery until recently [8]. We have
previously used another ICG-FI device [6]. SPY Elite is an
evolution of the other infrared camera; however, it main-
tains the same principles. Indeed, the main changes are
found in the software for analyzing the results, making
them easier to achieve and therefore even faster to analyze.
The analysis of perfusion in the ROI is more accurate with
the new device, owing to the better resolution of the
camera. With the SPY-Q software, a single frame of each
recording can be measured in units of absolute perfusion
applied to the ROI. The unit of absolute perfusion is based
on a standardized scale pixel gray gradient from 0 to 255.
The automatic baseline setting was used for all patients in
order to compensate for any differences in intensity and for
residual IC in the circulatory system that might bias the
quantitative assessment and visualization. In addition, the
Table 2 Analysis of 104 limbs




SPY ingress before 77.79 33 50.0 8.70
SPY ingress after 134.17 33 51.96 9.04
SPY ingress rate before 4.86 33 6.12 1.06
SPY ingress rate after 10.15 33 5.28 0.92
SPY10 before 26.58 33 33.93 5.90
SPY10 after 69.74 33 34.39 5.98
ABI before 0.41 11 0.14 0.04
ABI after 0.63 11 0.29 0.08
TP before 29.08 12 12.07 3.48
TP after 30.33 12 12.84 3.70
PTA
62 limbs
Ingress before 83.33 62 46.35 5.88
Ingress after 113.07 62 55.94 7.10
Ingress rate before 3.91 62 4.15 0.52
Ingress rate after 6.80 62 6.30 0.80
SPY 10 before 25.96 62 20.37 2.58
SPY 10 after 53.96 62 44.45 5.64
ABI before 0.65 26 0.21 0.42
ABI after 0.85 26 0.20 0.40
TP before 41.15 33 22.39 3.89
TP After 49.54 33 20.77 3.61
Technical failure PTA
9 limbs
Ingress before 109.07 9 52.79 17.59
Ingress after 83.9 9 57.13 19.04
Ingress rate before 5.35 9 4.96 1.65
Ingress rate after 2.83 9 4.23 1.41
SPY 10 before 24.0 9 20.17 6.72
SPY 10 after 18.7 9 22.68 7.56
ABI before 0.58 6 0.21 0.08
ABI after 0.72 6 0.21 0.08
TP before 40.29 7 38.65 14.60
TP after 46.42 7 25.71 9.71
Three groups were separately studied
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equipment includes an arm for holding the camera, which
provides different positions of the camera related to the
foot.
In order to assess the vascularization of our patients,
for this study, one of the applications of the SPY-Q
program was used that allows the comparison of the
curves of perfusion before and after the procedure. We
analyzed the values of intensity and intensity rate in each
ROI before and after the revascularization. The analysis
was based on measurements taken over the entire exam
and during a span of 10 s to provide a comparative
display of the perfusion of the foot. Terasaki [6], in a
study on patients with peripheral arterial disease,
described a perfusion time of 10 s in normal healthy
patients; this time, which does not depend on the device,
was adopted as the reference value in our study to
graphically quantify an index of good perfusion in the
selected ROIs. The intensity value reports the total
change in blush from the start to maximum values. The
‘‘intensity rate’’ describes the average rate at which the
blush changes during the intensity. ICG with a SPY
device has been reported for the intraoperative assess-
ment of perfusion in plastic and reconstructive surgery.
Clinical studies have demonstrated the ability of SPY
analysis to preoperatively evaluate any zones of the flap
suffering from ischemia to reduce the risk of postoper-
ative complications and re-interventions.
The potential utility of this new method remained
unknown to vascular surgeons for a long time. Terasaki
et al. [6] published quantitative information about the
perfusion of the area of interest, first describing a quanti-
tative evaluation using ICG fluorescence in patients with
lower-limb arterial diseases. Unno et al. [7] used ICG to
assess the patency of preoperative bypass in 6 patients,
demonstrating the absence of the passage of green into the
occluded bypass. In a small study, Braun et al. [7] used
SPY Elite before and after revascularization in 13 patients.
They reported significant increase in the intensity after the
revascularization in all patients and concluded that this
method provides rapid qualitative visual and quantitative
information about regional foot perfusion.
By comparing the preoperative and postoperative
intensity curves in the same ROI, it is possible to evaluate
the perfusion of the foot. In our series of patients in whom
PTA or bypass was successful, SPY analysis revealed that
the intensity as well as the intensity and intensity rate
increased, while in patients whose PTA was unsuccessful,
the intensity and/or IR remained unchanged or with non-
significant modifications. The statistical analysis revealed
that, for some patients, the intensity and an intensity rate
decreased after the procedure. These results suggest that
the perfusion of the foot became worse after surgery.
Indeed, analyzing the individual cases, worse distal per-
fusion was related to distal embolization in two cases and a
Fig. 3 Time–intensity curve for the first 10 s before (top) and after (below) the revascularization in a patient who underwent recanalization of
anterior tibial artery using pedal access. ICG-FI shows poorer intensity in forefoot distal to the puncture site
1924 World J Surg (2017) 41:1919–1926
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thrombosis of the distal pedal artery in one patient who
underwent PTA retrograde pedal access, although the final
angiographic control showed a patent artery before an
introducer sheath retry. The utility of SPY, in these cases,
has been to allow the assessment foot perfusion early,
within 6 h after the procedure, permitting the early remedy
of postoperative complications with the ability to re-oper-
ate on these patients faster.
The values of SPY were compared with ABI and toe
pressure before and after the intervention. ABI and toe
pressure measurements have some clear disadvantages
when compared to ICG-FI. ABI is falsely elevated in many
cases, especially in diabetic patients. In the current study,
reliable ABI was available before and after the procedure
in only 48 (47.5%) patients. Toe pressures are more reli-
able but cannot be measured in one-third of patients. Also,
in many cases the values are available before the operation
but not after the operation as some minor amputations have
been done. In this series, only 52 (51.5%) patients had both
pre- and postoperative toe pressures. Furthermore, the
repeatability of toe pressure measurements is not excellent
[2]. With ICG-FI, the perfusion can be assessed from a
larger region, and in addition to numerical values, ICG-FI
provides visual information, which is very valuable. ICG-
FI is not reliable in feet with inflammation as the intensity
tends to be falsely elevated. Furthermore, if there is
necrotic tissue in the foot, SPY does not yield reliable
information. ICG-FI can also been used during the opera-
tion itself. The SPY device can be covered with a sterile
window for that purpose.
In this study, the increase in arterial perfusion as mea-
sured by ICG-FI was significantly higher after surgical
bypass as opposed to PTA. The same phenomenon can be
seen in ABI measurements. The preoperative baseline
values were worse in surgical patients, but after the pro-
cedure, the level of perfusion seemed to be on the same
level.
The ICG-FI image also has several limitations. For
example, we are not able to measure the circulation
straightly from wound area usually due to necrotic tissue
on the surface. Usually, necrotic tissue does not show any
fluorescence leading to false-positive finding, on the other
hand infection causing inflammation causes hyperemia and
false-negative finding regarding ischemia. Furthermore,
ICG seems to vary a lot between individuals. This means
that although the repeatability of the study is good and
comparison of the studies of an individual patient reflects
well the changes of perfusion, we have not been able to
define any normal values or thresholds for example to
critical ischemia. Costs of the ICG-FI equipment vary
between 50,000 and 150,000 euro depending on the device
and the software. The cost of ICG is about 5–10 euro per
patient. Although the cost of the device is high, the net cost
is lower if we are able to prevent major adverse limb events
with earlier diagnostics on the revascularization failure and
restenosis after revascularization.
There are many limitations in our study. Firstly, the
number of patients so far is limited, especially in the
bypass group. Furthermore, we do not currently have
surveillance data, which means that the clinical meaning of
the SPY values remains unknown. In the future, we aim to
follow these patients and compare the ICG-FI data against
their wound healing and ability to predict failure of bypass.
In our series, the results of SPY analysis are in agree-
ment with the real perfusion of the foot. In our experience,
this noninvasive analysis can be useful in terms of
assessing the perfusion of the foot after distal revascular-
ization by means of PTA or bypass.
We think that ICG-FI may be a useful exploration in
patients who undergo distal revascularization due to CLI
and tissue lesion, before and after the revascularization and
thereafter during the follow-up until the wound is healed.
Significant worsening of the ICG-FI is a signal for
restenosis and the need of further imagining.
Patients in whom the post-procedure SPY analysis
reveals a worse intensity value need further investigations
as Doppler ultrasound or new angiography to check for
distal embolization or early thrombosis of the revascular-
ized arteries.
Conclusions
ICG-FI with SPY Elite provides reliable information on
increase in perfusion after revascularization, in addition to
implicating possible failure in revascularization if there is
no improvement in the ICG-FI variables. ICG-FI may help
to distinguish possible problem in revascularization earlier,
and thus may prevent major adverse limb events. It gives
valuable information complement to traditional assessment
methods ABI and TP, which are many times not applicable.
According to our study, the increase in perfusion is higher
when surgical bypass is performed as opposed to
endovascular revascularization. Further studies are needed
to evaluate the benefit of this new method of follow-up and
would healing prediction.
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Lepäntalo M, Inoue Y, Terasaki H (2016) Pilot assessment of the
repeatability of indocyanine green fluorescence imaging and
correlation with traditional foot perfusion assessments. Eur J
Vasc Endovasc Surg 52:527–533
10. SPY-Q Analysis Toolkit Operator’s Manual Document:
012-50101-000 Edition: USA Revision: B, 2012 Printed in
Canada, pp 51–52
11. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn
S et al (1997) Recommended standards for reports dealing with
lower extremity ischemia: revised version. J Vasc Surg
26(3):517–538
12. Wyman RA, Keevil JG, Busse KL, Aeschlimann SE, Korcarz CE,
Stein JH (2006) Is the ankle-brachial index a useful screening test
for subclinical atherosclerosis in asymptomatic, middle-aged
adults? WMJ 105:50–54
13. De Graaff JC, Ubbink DT, Legemate DA, de Haan RJ, Jacobs MJ
(2001) Interobserver and intraobserver reproducibility of
peripheral blood and oxygen pressure measurements in the
assessment of lower extremity arterial disease. J Vasc Surg
33:1033–1040
14. Cheng Z, Wu Y, Xiong Z, Gambhir SS, Chen X (2005) Near-
infrared fluorescent RGD peptides for optical imaging of integrin
alphavbeta3 expression in living mice. Bioconjug Chem
16:1433–1441
15. Frangioni JV (2003) In vivo near-infrared fluorescence imaging.
Curr Opin Chem Biol 7:626–634
16. Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin
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